- Home
- BDL vs VTVT Comparison
BDL vs VTVT Comparison
Compare BDL & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- VTVT
- Stock Information
- Founded
- BDL 1959
- VTVT 2015
- Country
- BDL United States
- VTVT United States
- Employees
- BDL N/A
- VTVT N/A
- Industry
- BDL Restaurants
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- VTVT Health Care
- Exchange
- BDL Nasdaq
- VTVT Nasdaq
- Market Cap
- BDL 60.8M
- VTVT 56.7M
- IPO Year
- BDL N/A
- VTVT 2015
- Fundamental
- Price
- BDL $29.05
- VTVT $14.64
- Analyst Decision
- BDL
- VTVT Strong Buy
- Analyst Count
- BDL 0
- VTVT 2
- Target Price
- BDL N/A
- VTVT $35.50
- AVG Volume (30 Days)
- BDL 3.1K
- VTVT 7.9K
- Earning Date
- BDL 08-12-2025
- VTVT 08-07-2025
- Dividend Yield
- BDL 1.72%
- VTVT N/A
- EPS Growth
- BDL 14.76
- VTVT N/A
- EPS
- BDL 2.18
- VTVT N/A
- Revenue
- BDL $198,785,000.00
- VTVT $17,000.00
- Revenue This Year
- BDL N/A
- VTVT N/A
- Revenue Next Year
- BDL N/A
- VTVT N/A
- P/E Ratio
- BDL $13.31
- VTVT N/A
- Revenue Growth
- BDL 9.31
- VTVT N/A
- 52 Week Low
- BDL $22.61
- VTVT $12.12
- 52 Week High
- BDL $35.98
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- BDL 45.79
- VTVT 40.96
- Support Level
- BDL $30.11
- VTVT $14.53
- Resistance Level
- BDL $35.18
- VTVT $16.76
- Average True Range (ATR)
- BDL 0.99
- VTVT 0.62
- MACD
- BDL -0.47
- VTVT 0.04
- Stochastic Oscillator
- BDL 0.00
- VTVT 25.11
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.